Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA.HIVA vaccine in healthy Gambian infants
PACTR2008120000904116Completed
- Sponsor
- Medical Research Council
- Start
- Dec 2009
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Trial of MVA.HIVA in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Medical Research Council. Primary endpoints: Safety of MVA.HIVA vaccine and Immunogenicity of MVA.HIVA vaccine. Started Dec 2009; status: completed.
02
Drugs
MVA.HIVA
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR2008120000904116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2008120000904116.